ABOUT AFC JAPAN

Founded in 1969 by Asayama Tadahiko, AFC-HD AMS Life Science Co., Ltd is Japan's leading health and skincare manufacturer. In 2005, it became the first company in Japan's health food industry to be publicly listed on the JASDAQ Stock Exchange (Stock No. 2927) and to obtain GMP certification. Renowned for its exceptional product quality, social responsibility and innovative vision, AFC Group has earned its place as one of Japan's top five health and beauty brands. Over the years, the group has grown into a global brand, operating through four subsidiary companies across five specialized divisions.

AFC stands for 'Asayama Family Club'.

Japan's Leading Health & Beauty Innovator

• AFC HD AMS Life Science Co. Ltd – Headquarters managing global operations and serving as the main production hub for OEM customers.

• NYK – Nihon Preventive Medical Laboratory – Established in 1983, leading research, product development, and quality evaluation.

• Honzo Pharmaceutical Herbal Medicine – A pioneer in herbal medicine since 1831, became a subsidiary of AFC in 2007, supplying products to hospitals and contributing to AFC's premium offerings.

• Kenko TV Co. Ltd – Since 2004, handling media and marketing through TV, advertisements and health-focused content.

• AFC Co. Ltd – Overseeing local and international wholesale and retail distribution via exclusive partnerships, online platforms and 117 chain stores.

TADAHIKO ASAYAMA

AFC's Chairman & Founder

A Legacy of Excellence Since 1969

As of today, all four manufacturing facilities of AFC-HD AMS Life Science Co., Ltd. are GMP certified. The Chiba factory has also obtained Organic JAS certification ('Production Process Manager/Re-packer' and 'Importer') from the Japan Food Research Laboratories (JFRL). Additionally, NYK Nihon Preventive Medical Laboratory holds ISO/IEC 17025:2005 certification. AFC Peptide Products are rigorously tested and certified to be free from antibiotics, pesticides, heavy metals, harmful chemicals, hormones and nuclear radiation contamination.

AFC-HD AMS Life Science Co., Ltd. has a dedicated team of 1,000 employees, generating an annual turnover of JPY15 billion (approximately USD $134 million). With over five decades of expertise, the AFC Group continues to deliver innovative, premium-quality health and beauty solutions worldwide.

AFC Group Important Milestones

About AFC LIFE SCIENCE
Indonesia

AFC Life Science Indonesia was established in 2019 when an exclusive distributorship was granted by for AFC-HD AMS Life Science Co., Ltd to PT H&E Dermatech Indonesia, for distributing AFC's revolutionary peptide supplements through direct-selling model. With a commitment to improving health and well-being, the Company has since introduced 4 premium products: SOP Subarashi, Utsukushhii, Hikari and Sensei Suru.

AFC Life Science: A Trailblazer in the Direct Selling Industry

AFC's unique and clinically proven peptide products have rapidly gained widespread recognition due to their exceptional efficacy. Supported by countless customer testimonials, these products have demonstrated remarkable improvements in areas such as:

• Cancer and tumor management

• Skin health and mobility challenges

• Stroke recovery

• Diabetes care

• Liver and kidney health

• many more

AFC Life Science's extraordinary impact has earned the Company several prestigious accolades, including:

1. MURI (Museum Rekor-Dunia Indonesia) Record-Breaking Achievements

A museum organization dedicated to recognise and document achievements within Indonesia, showcasing the country's best and most unusual accomplishments

• 2019: Grand Launch Event with the Highest Number of Invitations (1,010) on a Cruise Ship

• 2020: Health Supplement Import Company with the Highest Air Shipment Volume in One Week

• 2021: Direct Selling Company with the Largest Bonus Payout (112 Billion Rupiah)

• 2023: Network Marketing Company Hosting the Most Meetings

• 2024: Highest Product Sales During a Launch (17,589 Boxes of Hikari Sold in 4 Hours)

2. Helmy Attamimi Awards

A biennial award presented by the Indonesian Direct Selling Association (AP2LI) to recognize excellence in the direct selling industry:

• 2020: Product of the Year

• 2022:

  • Product of the Year

  • Member Growth of the Year

• 2024:

  • MLM of the Year

  • CEO of the Year

  • Member Growth of the Year

  • Best Selling Product of the Year

3. Global Recognition

• 2021: Certificate of Achievement - No. 1 Sales Worldwide – Awarded by AFC Japan

With these outstanding achievements, AFC Life Science has set new benchmarks for innovation, growth and customer satisfaction in the direct selling industry.

Earnest Prayuda
Founder

Michael Tampi
Co-Founder

AFC Life Science: Empowering Health, Changing Lives

At AFC Life Science, we are more than just a health brand—we are a movement. With over 2 million registered customers and distributors and 2 million units sold annually, we are empowering people to take charge of their well-being through science-backed, premium health solutions.

2024 marks a groundbreaking chapter as we embark on global expansion. In April 2025, we proudly open our doors to the Malaysian market, bringing our life-changing peptide supplements to even more people. And we're just getting started—plans are already underway to establish offices in Hong Kong, Singapore, the USA and Australia, extending the power of advanced wellness to every corner of the world.

Together, we can make a difference. This is your chance to be part of something bigger. Join us in transforming health, enhancing lives, and shaping the future—one breakthrough at a time.

We'd love to hear from you! Whether it's product inquiries or partnership opportunities, our team is ready to assist you on your wellness journey.